Breast cancer is a heterogenous disease, which can be classified using gene and protein expression into basic subclasses based on the expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast cancer.